Cargando…

Rosiglitazone improves the natriuretic response to atrial natriuretic peptide in rats with experimental congestive heart failure: possible involvement of a post-guanylate cyclase mechanism

Detalles Bibliográficos
Autores principales:	Goltsman, Ilia, Ovcharenko, Elena, Hoffman, Aaron, Feuerstein, Giora, Abassi, Zaid, Winaver, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363222/ http://dx.doi.org/10.1186/1471-2210-11-S1-P29

Ejemplares similares

Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure
por: Goltsman, Ilia, et al.
Publicado: (2019)

Renal effects of a novel endogenous natriuretic agent xanthurenic acid 8-o-β-d-glucoside in rats
por: Hoffman, Aaron, et al.
Publicado: (2013)

Aortocaval Fistula in Rat: A Unique Model of Volume-Overload Congestive Heart Failure and Cardiac Hypertrophy
por: Abassi, Zaid, et al.
Publicado: (2011)

Atrial natriuretic factor receptor guanylate cyclase, ANF-RGC, transduces two independent signals, ANF and Ca(2+)
por: Duda, Teresa, et al.
Publicado: (2014)

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015)

Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence
por: Koratala, Abhilash, et al.
Publicado: (2017)

Inhibition of endogenous ouabain by atrial natriuretic peptide is a guanylyl cyclase independent effect
por: Tegin, Gulay, et al.
Publicado: (2021)

A splice variant of the guanylyl cyclase-A receptor interferes with atrial natriuretic peptide (ANP) signaling
por: Hartmann, Michael, et al.
Publicado: (2009)

Interpretation and Use of Natriuretic Peptides in Non-Congestive Heart Failure Settings
por: Tsai, Shih-Hung, et al.
Publicado: (2010)

Hyperbaric oxygen treatment improves GFR in rats with ischaemia/reperfusion renal injury: a possible role for the antioxidant/oxidant balance in the ischaemic kidney
por: Rubinstein, Irit, et al.
Publicado: (2009)

Homologous desensitization of guanylyl cyclase A, the receptor for atrial natriuretic peptide, is associated with a complex phosphorylation pattern
por: Schröter, Juliane, et al.
Publicado: (2010)

Cardiac congestion assessed by natriuretic peptides oversimplifies the definition and treatment of heart failure
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

Atrial Natriuretic Peptide and Adiponectin Interactions in Man
por: Birkenfeld, Andreas L., et al.
Publicado: (2012)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Awareness of atrial fibrogenesis and natriuretic peptide release
por: Meijers, W. C. F. W., et al.
Publicado: (2017)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

Guanylyl cyclase/natriuretic peptide receptor-A: Identification, molecular characterization, and physiological genomics
por: Pandey, Kailash N.
Publicado: (2023)

Correlation of natriuretic peptides and inferior vena cava size in patients with congestive heart failure
por: Hebl, Virginia, et al.
Publicado: (2012)

Great Tool or Gold Standard? B-Type Natriuretic Peptide and Congestive Heart Failure
por: Montez, Jeremy, et al.
Publicado: (2011)

Ratio of preoperative atrial natriuretic peptide to brain natriuretic peptide predicts the outcome of the maze procedure in mitral valve disease
por: Sato, Masafumi, et al.
Publicado: (2013)

Is Atrial Natriuretic Peptide (ANP) and Natriuretic Peptide Receptor-A (NPR-A) Expression in Human Placenta and Decidua Normal?
por: Tan, Hongchuan, et al.
Publicado: (2019)

Atrial natriuretic peptide and leptin interactions in healthy men
por: Daniels, Martin A., et al.
Publicado: (2023)

Heads and Tails of Natriuretic Peptides: Neuroprotective Role of Brain Natriuretic Peptide
por: Fernández‐Susavila, Héctor, et al.
Publicado: (2017)

Natriuretic Peptide Signaling via Guanylyl Cyclase (GC)-A: An Endogenous Protective Mechanism of the Heart
por: Kishimoto, Ichiro, et al.
Publicado: (2009)

Genetic Ablation and Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Impact on the Pathophysiology of Cardiovascular Dysfunction
por: Pandey, Kailash N.
Publicado: (2019)

Epitope-tagged and phosphomimetic mouse models for investigating natriuretic peptide-stimulated receptor guanylyl cyclases
por: Egbert, Jeremy R., et al.
Publicado: (2022)

Midregional pro-atrial natriuretic peptide, an important member of the natriuretic peptide family: potential role in diagnosis and prognosis of cardiovascular disease
por: Idzikowska, Karolina, et al.
Publicado: (2018)

Inverse association of long-acting natriuretic peptide with metabolic syndrome in congestive heart failure patients
por: Wang, Ji-Hung, et al.
Publicado: (2013)

Recombinant human brain natriuretic peptide ameliorates venous return function in congestive heart failure
por: Luo, Jing‐chao, et al.
Publicado: (2022)

The Transition of Photoreceptor Guanylate Cyclase Type 1 to the Active State
por: Shahu, Manisha Kumari, et al.
Publicado: (2022)

Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A
por: Vink, Simone, et al.
Publicado: (2023)

Natriuretic peptides system in the pulmonary tissue of rats with heart failure: potential involvement in lung edema and inflammation
por: Khoury, Emad E., et al.
Publicado: (2018)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

β Cell-specific deletion of guanylyl cyclase A, the receptor for atrial natriuretic peptide, accelerates obesity-induced glucose intolerance in mice
por: Tauscher, Sabine, et al.
Publicado: (2018)

Atrial Natriuretic Peptide Induces Postprandial Lipid Oxidation in Humans
por: Birkenfeld, Andreas L., et al.
Publicado: (2008)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Atrial Natriuretic Peptide in Young and Elderly Children with Mild Gastroenteritis
por: Klar, A., et al.
Publicado: (2009)

Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
por: Frøssing, Signe, et al.
Publicado: (2017)

Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans
por: Zois, Nora E., et al.
Publicado: (2017)

Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation
por: Baba, Masako, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lrqsbs2dkd6v5eiic8ocfj5iso